Pacemaker syndrome is an under-recognized iatrogenic condition affecting up to 20% of patients with ventricular pacemakers, which can be alleviated by pacemaker upgrade.
Answers are grounded in this paper and cite their sources.
Supports heightened awareness of pacemaker syndrome in ventricular pacing; leaves open prospective evaluation of upgrade benefits.
Pacemaker syndrome was first described in 1969 by Mitsui when it was referred to as the pacemaking syndrome.' The name pacemaker syndrome was first coined by Erbel (using the German Schrittmacher syndrom) in 1979.2 It can present with symptoms as severe as syncope, presyncope, oedema, dyspnoea, and chest pain, or more moderately and subtly as lethargy, palpitation, or an awareness of venous pulsation all of which may occur when there is atrial systole during ventricular sys- tole. This is most frequent when there is ventriculoatrial conduction from the paced ventricle to the atrium usually via the atrioventricular node.34 The symptoms can be identical to those prompting implant.5 Occasionally pacemaker syndrome can occur in the absence of ventriculoatrial conduction when ventricular pacing is in competition with sinus rhythm.6 Incidence of pacemaker syndrome The incidence of pacemaker syndrome varies with the vigour with which it is sought and it probably affects 7% of all ventricularly paced patients in its severe form in which it is essential to revise the pacemaker. If mild to moderate symptoms are considered it affects 20% of the ventricularly paced. This group too can benefit clinically from pacemaker upgrade.7 All too often the symptoms and signs of the syndrome are not sought and patients who previously experienced syncope, now relieved, complain little. This leads to a widespread impression that the syndrome is rare.
No takes yet. Share an insight, caveat, or question.
Travill et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: